Inventor

SCHWEDE WOLFGANG

DE45 patents

⚠️ This page may combine multiple inventors who share the name “SCHWEDE WOLFGANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHWEDE WOLFGANG

SCHERING AG

18 Norsteroids as selectively active estrogens

Antigestagenically active steroids with a flourinated 17 α-alkyl chain

Antigestagenically active steroids with a fluorinated 17α-alkyl chain

Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chain

16-Halogen-epothilone derivatives, method for producing them and their pharmaceutical use

Antigestagenically active steroids with a fluorinated 17α-alkyl chain

6,7-modified 11β-aryl-4-oestrenes

6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations

14β-H-, 14-and 15-En-11β-aryl-4-oestrenes

16-halogen-epothilone derivatives, process for their production, and their pharmaceutical use

14α, 17α-C2 -bridged norprogesterone derivatives

D-homo-(16-ene)-11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents

Epothilon derivatives, method for the production and the use thereof as pharmaceuticals

Progestationally active 19,11-bridged 4-estrenes

Steroid esters, process for their production and their pharmaceutical use

14-α, 17-α-C2 bridged norprogesterone derivatives

Progestationally active 19,11-bridged 4-estrenes

Nonsteroidal progesterone receptor modulators

BAYER SCHERING PHARMA AG

3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents

6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations

6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations

Epothilone derivatives, method for producing same and their pharmaceutical use

Cyanoquinoline derivatives, their preparation, their use, and medicaments comprising them

Pyrazolopyridines and salts thereof, a pharmaceutical composition comprising said compounds, a method of preparing same and use of same

Substituted aminopyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same

Quinazoline derivatives, their preparation, their use, and medicaments comprising them

KLAR ULRICH

17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and the use thereof for treating diseases

17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-methylene oxyalkylene aryl derivatives, process for preparation thereof, and use thereof for treatment of diseases

17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylene phenyl derivatives, methods for the production thereof and use thereof for treating diseases

17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzylidene derivatives, methods for the production thereof and use thereof for treating diseases

17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-ethynylphenyl derivatives, methods for the production thereof and use thereof for treating diseases

DAIMLER BENZ AG

Self-supporting motor-vehicle

Erecting mechanism for a swivel-up rollover bar

Axially adjustable steering device for motor vehicles

Roll bar for a motor vehicle

Bayer Pharma AG

Benzimidazol-2-amines as mIDH1 inhibitors

Benzimidazol-2-amines as MIDH1 inhibitors

Benzimidazol-2-amines as mIDH1 inhibitors

Substituted pyridyl-cycloalkyl-carboxylic acids, compositions containing them and medical uses thereof

SCHWEDE WOLFGANG

17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases

Progesterone receptor antagonists

Progesterone receptor antagonists

BAYER IP GMBH

17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases

17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases

SCHERING AKITENGESELLSCHAFT

14-α,17-α-C2 -bridged norprogesterone derivatives